Want to see AU:ADR full AI Analyst Report?
ADR Stock Chart & Stats
AU$0.01
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.01
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.11 - AU$0.19
Previous CloseN/A
Volume40.01K
Average Volume (3M)1.17M
Market Cap
AU$7.14M
Enterprise ValueAU$10.60
Total Cash (Recent Filing)AU$642.27K
Total Debt (Recent Filing)AU$1.33M
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding54,887,672
10 Day Avg. Volume107,278
30 Day Avg. Volume1,170,790
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.76
Price to Sales (P/S)4.40
P/FCF Ratio-0.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)99.26
Revenue Forecast (FY)AU$54.78M
Bulls Say, Bears Say
Bulls Say
Recurring Digital Services ModelAdherium’s business model includes recurring software and data-service fees alongside device sales, creating subscription-like, predictable revenue streams. Over 2–6 months this supports stable cash inflows, customer stickiness, and a pathway to margin improvement as service scale grows.
Pharma And Healthcare Collaboration PipelinePartnerships with pharma and healthcare organizations provide structural demand, validation and potential multi-year program revenues. Such collaborations often yield recurring project work, milestones and licensing, strengthening revenue visibility and commercial traction over the medium term.
Positive Free Cash Flow To Net Income MetricA free cash flow to net income ratio ~1.0 indicates the company can, in aggregate, convert reported losses into comparable cash flow in the period. This suggests some cash conversion resilience, which moderates liquidity risk and supports operations while management pursues scale or partnership revenue.
Bears Say
Negative Shareholders' EquityNegative equity is a structural solvency concern that limits financing flexibility and heightens refinancing risk. It can constrain the company’s ability to raise debt or attract long-term investors, forcing reliance on dilutive equity or short-term funding, which affects sustainability over months.
Persistent Operating Losses And Weak MarginsSustained negative margins indicate operational inefficiency or insufficient scale. Continued operating losses pressure retained cash and make it harder to invest in commercialization. Without clear path to margin recovery, profitability risk remains elevated over the medium term.
Deteriorating Cash GenerationDeclining free cash flow and OCF that doesn’t cover net losses reveal weakening cash generation and operational cash burn. This trend increases the likelihood of needing external financing or dilutive capital within months if revenue or margins don’t improve.
Adherium Ltd. News
ADR FAQ
What was Adherium Ltd.’s price range in the past 12 months?
Adherium Ltd. lowest share price was AU$0.11 and its highest was AU$0.19 in the past 12 months.
What is Adherium Ltd.’s market cap?
Adherium Ltd.’s market cap is AU$7.14M.
When is Adherium Ltd.’s upcoming earnings report date?
Adherium Ltd.’s upcoming earnings report date is Aug 28, 2026 which is in 43 days.
How were Adherium Ltd.’s earnings last quarter?
Adherium Ltd. released its earnings results on Feb 27, 2026. The company reported -AU$0.298 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Adherium Ltd. overvalued?
According to Wall Street analysts Adherium Ltd.’s price is currently Overvalued.
Does Adherium Ltd. pay dividends?
Adherium Ltd. does not currently pay dividends.
What is Adherium Ltd.’s EPS estimate?
Adherium Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adherium Ltd. have?
Adherium Ltd. has 54,887,672 shares outstanding.
What happened to Adherium Ltd.’s price movement after its last earnings report?
Adherium Ltd. reported an EPS of -AU$0.298 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -15.385%.
Which hedge fund is a major shareholder of Adherium Ltd.?
Currently, no hedge funds are holding shares in AU:ADR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Adherium Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ADR Sentiment 100%
Sector Average 67%
Sector Average 67%
Insider Transactions
Bought Shares
Worth AU$345.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
459.94%
Trailing 12-Months
Asset Growth
-14.68%
Trailing 12-Months
Company Description
Adherium Ltd.
Adherium Limited specializes in developing, manufacturing, and providing advanced digital health solutions. The company's core mission is to enhance medication adherence for individuals managing chronic conditions in key international markets, spanning New Zealand, Australia, Europe, North America, and Asia. A central offering is Hailie, a comprehensive system engineered to optimize medication use for patients suffering from chronic respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD). This innovative solution integrates Bluetooth-enabled Hailie sensors, which discreetly attach to patients' inhalers to deliver immediate feedback. The Hailie ecosystem is further supported by an intuitive mobile application and a dedicated online portal. Established in 2001, Adherium Limited is headquartered in Auckland, New Zealand.
Technical Analysis
Beamtree Holdings Ltd
―
MedAdvisor Limited
―
Alcidion Group Limited
―
InteliCare Holdings Limited
―
PainChek Ltd
―